NCT02511158 French Prospective Anterior Cruciate Ligament Reconstruction Cohort Study (FAST)
| NCT ID | NCT02511158 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fonds de Dotation pour la Recherche Clinique en Orthopédie et Pathologie du Sport |
| Condition | Rupture of Anterior Cruciate Ligament |
| Study Type | OBSERVATIONAL |
| Enrollment | 7,000 participants |
| Start Date | 2012-09 |
| Primary Completion | 2032-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 7,000 participants in total. It began in 2012-09 with a primary completion date of 2032-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study we will examine patients who have undergone anterior cruciate and/or posterior cruciate ligament and/or multi ligaments reconstruction to determine the rate of re-injury, contralateral tear and functional outcomes at least two years after surgery.
Eligibility Criteria
Inclusion Criteria: * One ligament or multi-ligaments tear of the knee * Surgery reconstruction with any technique Exclusion Criteria: * Patient refusal
Contact & Investigator
Frequently Asked Questions
Who can join the NCT02511158 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, studying Rupture of Anterior Cruciate Ligament. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02511158 currently recruiting?
Yes, NCT02511158 is actively recruiting participants. Contact the research team at klouche_shahnaz@yahoo.fr for enrollment information.
Where is the NCT02511158 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT02511158 clinical trial?
NCT02511158 is sponsored by Fonds de Dotation pour la Recherche Clinique en Orthopédie et Pathologie du Sport. The trial plans to enroll 7,000 participants.